chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 5.0
Sex: M
Vaccine: DTAP, HEPA
Symptoms: Anorexia, Contusion, Cough, Dizziness, Dyspnoea
Clinical narrative: I received my son on Sunday, the 21st, at 5:oo p.m. He was complaining of not feeling well. He ran a fever, was dizzy, had difficulty breathing, mouth hurt, paleness, wheezing, sound of phlem build up in chest and rattled when he would cough, fast heartbeat, dizziness, loss of appetite, headache, tiredness, and soreness and bruising where shot was administered.
Age: 5.0
Sex: M
Vaccine: DTAP, HEPA
Symptoms: Fatigue, Headache, Injection site pain, Injection site reaction, Malaise
Clinical narrative: I received my son on Sunday, the 21st, at 5:oo p.m. He was complaining of not feeling well. He ran a fever, was dizzy, had difficulty breathing, mouth hurt, paleness, wheezing, sound of phlem build up in chest and rattled when he would cough, fast heartbeat, dizziness, loss of appetite, headache, tiredness, and soreness and bruising where shot was administered.
Age: 5.0
Sex: M
Vaccine: DTAP, HEPA
Symptoms: Oral pain, Pallor, Pyrexia, Tachycardia, Wheezing
Clinical narrative: I received my son on Sunday, the 21st, at 5:oo p.m. He was complaining of not feeling well. He ran a fever, was dizzy, had difficulty breathing, mouth hurt, paleness, wheezing, sound of phlem build up in chest and rattled when he would cough, fast heartbeat, dizziness, loss of appetite, headache, tiredness, and soreness and bruising where shot was administered.
Age: 1.0
Sex: M
Vaccine: VARCEL
Symptoms: Blister, Decreased appetite, Irritability, Rash papular, Viral infection
Clinical narrative: Two days after varicella vaccination patient was noted to be fussy with multiple (greater than 50) papules and vesicles starting on hands and feet, then spreading to chest, abdomen, and face.  The papules and vesicles were small, 2-3 mm in diameter, and self-limited with resolution within 3 days.  Patient was mildly fussy with decreased appetite but afebrile throughout the course of illness.  Providing doctor discussed that possibly unrelated viral syndrome, but with proximity to varicella vaccine would report through the system.
Age: 33.0
Sex: M
Vaccine: VARCEL
Symptoms: Rash maculo-papular
Clinical narrative: macular papular lesions, approx seven of different stages, occuring three weeks after vaccination, called cdc
Age: 22.0
Sex: F
Vaccine: TYP
Symptoms: Arthralgia, Dizziness, Malaise, Pyrexia, Tachycardia
Clinical narrative: 45 minutes after taking the first dose of the live oral vaccine,the patient started experiencing malaise, joint pain, dizziness, increased heart rate and a fever of 101 degrees farenheit. The patient stated that she had taken the entire vaccine course about 10 years ago with no adverse reactions. The patient denies illness prior to taking the vaccine. The vaccine regimen was stopped and the patient's symptoms were treated accordingly with over-the-counter medications.
Age: 5.0
Sex: M
Vaccine: DTAP, MMR
Symptoms: Pyrexia
Clinical narrative: Child developed high grade fever approximately 8 hours after vaccination. Fever peaked to 103.5 F. Improved after treatment with Ibuprofen after 2 days.
Age: 50.0
Sex: F
Vaccine: HEPA, MEN, TD, TYP
Symptoms: Dizziness, Flushing, Pruritus
Clinical narrative: Flushing and subjective pruritus 1 hour after vaccination.  Some lightheadedness, but stable blood pressure and no dyspnea or LOC.
Age: 25.0
Sex: F
Vaccine: ANTH
Symptoms: Hypothyroidism
Clinical narrative: Diagnosed with Hypothyroidism May 2005.
Age: 66.0
Sex: M
Vaccine: IPV, TTOX, YF
Symptoms: Asthenia, Herpes zoster, Malaise, Pyrexia
Clinical narrative: One later after vaccination got low fever, he didn't feel good, and got no energy. Also he was getting tender spots from the torso. Today has been three weeks, and he doesn't have fever but he still has the tender spots they rotate around his torso The family doctor said it may be shingles, but he has no rash, he also thinks it may be reaction to the vaccination. I talk to the RN in the Health Department, and she suggested to file this report.
Age: 14.0
Sex: F
Vaccine: MMR
Symptoms: Arthralgia, Hyperhidrosis, Lymphadenopathy, Malaise, Neck pain
Clinical narrative: Two weeks after the MMR immunization was received, the child complained of severe neck pain. She developed a papular rash on her face that spread to her neck, chest, arms, then over her whole body.  She experienced joint pains, and the mother reports she had pus on her right tonsil.  She also had swelling of sub lingual lymph glands.  She had a low grade fever, malaise and sweats.  She felt sick for 5 days, but the rash didn't clear for 14 days.  She still has a slightly swollen lymph node behind her ear, but otherwise feels fine.
Age: 14.0
Sex: F
Vaccine: MMR
Symptoms: Pyrexia, Rash papular
Clinical narrative: Two weeks after the MMR immunization was received, the child complained of severe neck pain. She developed a papular rash on her face that spread to her neck, chest, arms, then over her whole body.  She experienced joint pains, and the mother reports she had pus on her right tonsil.  She also had swelling of sub lingual lymph glands.  She had a low grade fever, malaise and sweats.  She felt sick for 5 days, but the rash didn't clear for 14 days.  She still has a slightly swollen lymph node behind her ear, but otherwise feels fine.
Age: 0.23
Sex: M
Vaccine: DTAP, HIBV, IPV
Symptoms: Convulsion, Dyspnoea, Loss of consciousness, Speech disorder, Vomiting
Clinical narrative: Seizures, vomiting, heavy breathing, loss of consciousness. ER sent son home with just tylenol. Son is now speech delayed.
Age: 59.0
Sex: M
Vaccine: HEPA
Symptoms: Myelitis transverse
Clinical narrative: Transverse Myelitis, 3 weeks after vaccine. Treated with steroids and IV-IG. Prognosis unknown.
Age: 15.0
Sex: M
Vaccine: MNQ
Symptoms: Hyperhidrosis, Nausea, Urticaria
Clinical narrative: About 5 minutes after receiving vaccine pt became nauseated and sweaty. He than broke out in hives, All symptoms resolved after about one hour.
Age: 5.0
Sex: M
Vaccine: DTAP, IPV, MMR
Symptoms: Pain, Swelling
Clinical narrative: Swelling and pain - given orapred and benadryl in ER.
Age: 4.0
Sex: M
Vaccine: DTAP
Symptoms: Injection site reaction
Clinical narrative: Called MD large localized reaction the size of parents hand.  Treatment Benadryl, ice, follow up with doctor.
Age: 15.0
Sex: F
Vaccine: PPV
Symptoms: Dyspnoea, Myalgia
Clinical narrative: Patient is receiving vaccines in preparation for cochlear surgery.  After vaccination muscle soreness that afternoon.  On 08/05/ at 01:30 began to mow lawn but had to stop and rest because experiencing breathing problems got well after resting.  On 08/06 no problems noted.  On 08/07 also had breathing problems but might have been due to menstrual period was starting.  Mom usually experiences similar problems.  On 08/10 patient again had breathing problems when just started to Mow lawn.  Patient has been performing this type of activity all summer with no problems, only difference this instance is the vaccine.  On 08/10 had an adjustment with the chiropractor.  On 08/17 had another adjustment and complained of breathing problems after appointment, at 11PM had hard time breathing, Benadryl given.  On 08/18 had adjustment session for opening airways before leaving for camp, adjusted front of chest.  On 08/12, 08/17, 08/18 chiropractor mentioned that during the adjustment he found that the joints on left side were tight (same as vax received).  On 08/19 left for camp.  Today 08/24 patient is feeling much better but complains of some breathing discomfort still.
Age: 1.29
Sex: F
Vaccine: MMR, VARCEL
Symptoms: Pyrexia, Rash maculo-papular, Viral infection
Clinical narrative: Rash onset 2 days after vaccination.  Fever 6 days after vaccination.  Exposure to playmate who had fever same week patient had MMR and Varivax.  Examined by doctor 08/15/2005 and 08/22/2005, possible viral syndrome, maculopapular rash left thigh.
Age: 0.19
Sex: M
Vaccine: DTAPHEPBIP, HIBV, PNC
Symptoms: Irritability, Pyrexia
Clinical narrative: Received Pediarix, HIB, PCV7 on 08/16.  Temperature increased on 08/17 and 08/18, acted well.  No fever on 08/19 till evening:  fussy, temperature 100 degrees, continued with Tylenol.  No fever 08/22 AM, 100.8 degrees temperature in the evening.  Septic within normal limits.  Was happy throughout the evening 08/19.  On 08/24 see in doctors office with temperature 98.7, perfect.
Age: 21.0
Sex: F
Vaccine: MEN
Symptoms: Injection site reaction, Pruritus, Rash
Clinical narrative: 10 x 8 CM local reaction right posterior arm at site of Meningococcal vaccine itchy rash first noted 08/21/2005.  Treated with Allegra 180MG by mouth, Benadryl 50md every 4 hours.
Age: 5.0
Sex: F
Vaccine: DTAP, IPV, MMR
Symptoms: Blister, Injection site hypersensitivity, Injection site oedema, Tenderness
Clinical narrative: From initial information received on Jul 08 2004 from a health care professional regarding an adverse event occurring in the USA, it was reported that a four year old female patient received her fifth dose of Daptacel, lot number C1614AA, administered intra muscularly in the left thigh, her fourth dose of Ipol, administered subcutaneously in the left thigh, and her second dose of MMR, lot number 1034N, administered subcutaneously in the right thigh at 3:00 pm on May 20 2004. The next day, on May 21 2004, the patients left thigh was red, tender and swollen. The left leg measured 3.5cm larger the the right leg and a large vesicle/bulbs approximately the size of a quarter developed on top of the left thigh. The patient recovered from these events. Per reporter this case had been submitted to VAERS. The reporter of this case is the same reporter of cases 200402304,200402305,200402306,200402307,200402308,200402309,200402310,200402311,200402312 and 200402322. From additional information received on Aug 23 2004 from the initial reporter, it was reported that the case was Reviewed. No additional information. No further information is anticipated, this case is considered closed.
Sex: M
Vaccine: DTAP, HEP, HIBV, IPV, MMR, PNC, VARCEL, MMR, VARCEL, IPV, IPV
Symptoms: Affect lability, Body temperature increased, Chills, Dehydration, Delirium
Clinical narrative: From initial information received on 3/10/05 from another manufacturer (HQWYE906427JAN05) regarding an adverse event occurring in the USA, it was initially reported by a consumer that a male patient (date of birth and age not reported) received a dose of IPOL on 5/12/04. The lot number, route and site of administration were not reported. An unspecified amount of time later that same year, the patient developed brain damage, neurological symptoms, immune system disorder, psychomotor hyperactivity, emotional disorder, personality change, malaise, lethargy, retching, headache, dehydration, eye irritation, impaired pupillary reflex, temperature regulation disorder, pharyngolaryngeal pain, pain in extremities, predisposition to disease, mydriasis, skin discoloration, abnormal feeling, metal poisoning and neurotoxicity. It is unknown whether the patient recovered from any of these events. The reporter of this case is the same reporter as case 200500529. (OMIC)
Sex: M
Vaccine: DTAP, HEP, HIBV, IPV, MMR, PNC, VARCEL, MMR, VARCEL, IPV, IPV
Symptoms: Drug toxicity, Eye irritation, Feeling hot, Headache, Hot flush
Clinical narrative: From initial information received on 3/10/05 from another manufacturer (HQWYE906427JAN05) regarding an adverse event occurring in the USA, it was initially reported by a consumer that a male patient (date of birth and age not reported) received a dose of IPOL on 5/12/04. The lot number, route and site of administration were not reported. An unspecified amount of time later that same year, the patient developed brain damage, neurological symptoms, immune system disorder, psychomotor hyperactivity, emotional disorder, personality change, malaise, lethargy, retching, headache, dehydration, eye irritation, impaired pupillary reflex, temperature regulation disorder, pharyngolaryngeal pain, pain in extremities, predisposition to disease, mydriasis, skin discoloration, abnormal feeling, metal poisoning and neurotoxicity. It is unknown whether the patient recovered from any of these events. The reporter of this case is the same reporter as case 200500529. (OMIC)
Sex: M
Vaccine: DTAP, HEP, HIBV, IPV, MMR, PNC, VARCEL, MMR, VARCEL, IPV, IPV
Symptoms: Immune system disorder, Lethargy, Malaise, Medication error, Mydriasis
Clinical narrative: From initial information received on 3/10/05 from another manufacturer (HQWYE906427JAN05) regarding an adverse event occurring in the USA, it was initially reported by a consumer that a male patient (date of birth and age not reported) received a dose of IPOL on 5/12/04. The lot number, route and site of administration were not reported. An unspecified amount of time later that same year, the patient developed brain damage, neurological symptoms, immune system disorder, psychomotor hyperactivity, emotional disorder, personality change, malaise, lethargy, retching, headache, dehydration, eye irritation, impaired pupillary reflex, temperature regulation disorder, pharyngolaryngeal pain, pain in extremities, predisposition to disease, mydriasis, skin discoloration, abnormal feeling, metal poisoning and neurotoxicity. It is unknown whether the patient recovered from any of these events. The reporter of this case is the same reporter as case 200500529. (OMIC)
Sex: M
Vaccine: DTAP, HEP, HIBV, IPV, MMR, PNC, VARCEL, MMR, VARCEL, IPV, IPV
Symptoms: Nervous system disorder, Neurotoxicity, Pain, Personality disorder, Pharyngolaryngeal pain
Clinical narrative: From initial information received on 3/10/05 from another manufacturer (HQWYE906427JAN05) regarding an adverse event occurring in the USA, it was initially reported by a consumer that a male patient (date of birth and age not reported) received a dose of IPOL on 5/12/04. The lot number, route and site of administration were not reported. An unspecified amount of time later that same year, the patient developed brain damage, neurological symptoms, immune system disorder, psychomotor hyperactivity, emotional disorder, personality change, malaise, lethargy, retching, headache, dehydration, eye irritation, impaired pupillary reflex, temperature regulation disorder, pharyngolaryngeal pain, pain in extremities, predisposition to disease, mydriasis, skin discoloration, abnormal feeling, metal poisoning and neurotoxicity. It is unknown whether the patient recovered from any of these events. The reporter of this case is the same reporter as case 200500529. (OMIC)
Sex: M
Vaccine: DTAP, HEP, HIBV, IPV, MMR, PNC, VARCEL, MMR, VARCEL, IPV, IPV
Symptoms: Psychomotor hyperactivity, Retching, Skin discolouration
Clinical narrative: From initial information received on 3/10/05 from another manufacturer (HQWYE906427JAN05) regarding an adverse event occurring in the USA, it was initially reported by a consumer that a male patient (date of birth and age not reported) received a dose of IPOL on 5/12/04. The lot number, route and site of administration were not reported. An unspecified amount of time later that same year, the patient developed brain damage, neurological symptoms, immune system disorder, psychomotor hyperactivity, emotional disorder, personality change, malaise, lethargy, retching, headache, dehydration, eye irritation, impaired pupillary reflex, temperature regulation disorder, pharyngolaryngeal pain, pain in extremities, predisposition to disease, mydriasis, skin discoloration, abnormal feeling, metal poisoning and neurotoxicity. It is unknown whether the patient recovered from any of these events. The reporter of this case is the same reporter as case 200500529. (OMIC)
Sex: M
Vaccine: DTAP, HEP, HIBV, IPV, MMR, PNC, VARCEL, MMR, VARCEL, IPV, IPV
Symptoms: Affect lability, Dehydration, Delirium, Drug toxicity, Eye irritation
Clinical narrative: From initial information received on 3/10/05 from another manufacturer (HQWYE906427JAN05) regarding an adverse event occurring in the USA, it was initially reported by a consumer that a male patient (date of birth and age not reported) received a dose of IPOL on 5/12/04. The lot number, route and site of administration were not reported. An unspecified amount of time later that same year, the patient developed brain damage, neurological symptoms, immune system disorder, psychomotor hyperactivity, emotional disorder, personality change, malaise, lethargy, retching, headache, dehydration, eye irritation, impaired pupillary reflex, temperature regulation disorder, pharyngolaryngeal pain, pain in extremities, predisposition to disease, mydriasis, skin discoloration, abnormal feeling, metal poisoning and neurotoxicity. It is unknown whether the patient recovered from any of these events. The reporter of this case is the same reporter as case 200500529. (OMIC)
Sex: M
Vaccine: DTAP, HEP, HIBV, IPV, MMR, PNC, VARCEL, MMR, VARCEL, IPV, IPV
Symptoms: Headache, Immune system disorder, Lethargy, Malaise, Mydriasis
Clinical narrative: From initial information received on 3/10/05 from another manufacturer (HQWYE906427JAN05) regarding an adverse event occurring in the USA, it was initially reported by a consumer that a male patient (date of birth and age not reported) received a dose of IPOL on 5/12/04. The lot number, route and site of administration were not reported. An unspecified amount of time later that same year, the patient developed brain damage, neurological symptoms, immune system disorder, psychomotor hyperactivity, emotional disorder, personality change, malaise, lethargy, retching, headache, dehydration, eye irritation, impaired pupillary reflex, temperature regulation disorder, pharyngolaryngeal pain, pain in extremities, predisposition to disease, mydriasis, skin discoloration, abnormal feeling, metal poisoning and neurotoxicity. It is unknown whether the patient recovered from any of these events. The reporter of this case is the same reporter as case 200500529. (OMIC)
Sex: M
Vaccine: DTAP, HEP, HIBV, IPV, MMR, PNC, VARCEL, MMR, VARCEL, IPV, IPV
Symptoms: Neurological symptom, Personality disorder, Pharyngolaryngeal pain, Psychomotor hyperactivity, Pupillary reflex impaired
Clinical narrative: From initial information received on 3/10/05 from another manufacturer (HQWYE906427JAN05) regarding an adverse event occurring in the USA, it was initially reported by a consumer that a male patient (date of birth and age not reported) received a dose of IPOL on 5/12/04. The lot number, route and site of administration were not reported. An unspecified amount of time later that same year, the patient developed brain damage, neurological symptoms, immune system disorder, psychomotor hyperactivity, emotional disorder, personality change, malaise, lethargy, retching, headache, dehydration, eye irritation, impaired pupillary reflex, temperature regulation disorder, pharyngolaryngeal pain, pain in extremities, predisposition to disease, mydriasis, skin discoloration, abnormal feeling, metal poisoning and neurotoxicity. It is unknown whether the patient recovered from any of these events. The reporter of this case is the same reporter as case 200500529. (OMIC)
Sex: M
Vaccine: DTAP, HEP, HIBV, IPV, MMR, PNC, VARCEL, MMR, VARCEL, IPV, IPV
Symptoms: Retching, Skin discolouration
Clinical narrative: From initial information received on 3/10/05 from another manufacturer (HQWYE906427JAN05) regarding an adverse event occurring in the USA, it was initially reported by a consumer that a male patient (date of birth and age not reported) received a dose of IPOL on 5/12/04. The lot number, route and site of administration were not reported. An unspecified amount of time later that same year, the patient developed brain damage, neurological symptoms, immune system disorder, psychomotor hyperactivity, emotional disorder, personality change, malaise, lethargy, retching, headache, dehydration, eye irritation, impaired pupillary reflex, temperature regulation disorder, pharyngolaryngeal pain, pain in extremities, predisposition to disease, mydriasis, skin discoloration, abnormal feeling, metal poisoning and neurotoxicity. It is unknown whether the patient recovered from any of these events. The reporter of this case is the same reporter as case 200500529. (OMIC)
Sex: M
Vaccine: DTAP, HEP, HIBV, IPV, MMR, PNC, VARCEL, MMR, VARCEL, IPV, IPV
Symptoms: Affect lability, Congenital brain damage, Dehydration, Derealisation, Drug toxicity
Clinical narrative: From initial information received on 3/10/05 from another manufacturer (HQWYE906427JAN05) regarding an adverse event occurring in the USA, it was initially reported by a consumer that a male patient (date of birth and age not reported) received a dose of IPOL on 5/12/04. The lot number, route and site of administration were not reported. An unspecified amount of time later that same year, the patient developed brain damage, neurological symptoms, immune system disorder, psychomotor hyperactivity, emotional disorder, personality change, malaise, lethargy, retching, headache, dehydration, eye irritation, impaired pupillary reflex, temperature regulation disorder, pharyngolaryngeal pain, pain in extremities, predisposition to disease, mydriasis, skin discoloration, abnormal feeling, metal poisoning and neurotoxicity. It is unknown whether the patient recovered from any of these events. The reporter of this case is the same reporter as case 200500529. (OMIC)
Sex: M
Vaccine: DTAP, HEP, HIBV, IPV, MMR, PNC, VARCEL, MMR, VARCEL, IPV, IPV
Symptoms: Eye irritation, Headache, Immune system disorder, Laryngitis, Lethargy
Clinical narrative: From initial information received on 3/10/05 from another manufacturer (HQWYE906427JAN05) regarding an adverse event occurring in the USA, it was initially reported by a consumer that a male patient (date of birth and age not reported) received a dose of IPOL on 5/12/04. The lot number, route and site of administration were not reported. An unspecified amount of time later that same year, the patient developed brain damage, neurological symptoms, immune system disorder, psychomotor hyperactivity, emotional disorder, personality change, malaise, lethargy, retching, headache, dehydration, eye irritation, impaired pupillary reflex, temperature regulation disorder, pharyngolaryngeal pain, pain in extremities, predisposition to disease, mydriasis, skin discoloration, abnormal feeling, metal poisoning and neurotoxicity. It is unknown whether the patient recovered from any of these events. The reporter of this case is the same reporter as case 200500529. (OMIC)
Sex: M
Vaccine: DTAP, HEP, HIBV, IPV, MMR, PNC, VARCEL, MMR, VARCEL, IPV, IPV
Symptoms: Malaise, Mydriasis, Nervous system disorder, Pain, Personality disorder
Clinical narrative: From initial information received on 3/10/05 from another manufacturer (HQWYE906427JAN05) regarding an adverse event occurring in the USA, it was initially reported by a consumer that a male patient (date of birth and age not reported) received a dose of IPOL on 5/12/04. The lot number, route and site of administration were not reported. An unspecified amount of time later that same year, the patient developed brain damage, neurological symptoms, immune system disorder, psychomotor hyperactivity, emotional disorder, personality change, malaise, lethargy, retching, headache, dehydration, eye irritation, impaired pupillary reflex, temperature regulation disorder, pharyngolaryngeal pain, pain in extremities, predisposition to disease, mydriasis, skin discoloration, abnormal feeling, metal poisoning and neurotoxicity. It is unknown whether the patient recovered from any of these events. The reporter of this case is the same reporter as case 200500529. (OMIC)
Sex: M
Vaccine: DTAP, HEP, HIBV, IPV, MMR, PNC, VARCEL, MMR, VARCEL, IPV, IPV
Symptoms: Pharyngolaryngeal pain, Psychomotor hyperactivity, Pupillary reflex impaired, Retching, Skin discolouration
Clinical narrative: From initial information received on 3/10/05 from another manufacturer (HQWYE906427JAN05) regarding an adverse event occurring in the USA, it was initially reported by a consumer that a male patient (date of birth and age not reported) received a dose of IPOL on 5/12/04. The lot number, route and site of administration were not reported. An unspecified amount of time later that same year, the patient developed brain damage, neurological symptoms, immune system disorder, psychomotor hyperactivity, emotional disorder, personality change, malaise, lethargy, retching, headache, dehydration, eye irritation, impaired pupillary reflex, temperature regulation disorder, pharyngolaryngeal pain, pain in extremities, predisposition to disease, mydriasis, skin discoloration, abnormal feeling, metal poisoning and neurotoxicity. It is unknown whether the patient recovered from any of these events. The reporter of this case is the same reporter as case 200500529. (OMIC)
Sex: M
Vaccine: DTAP, HEP, HIBV, IPV, MMR, PNC, VARCEL, MMR, VARCEL, IPV, IPV
Symptoms: Affect lability, Congenital brain damage, Drug toxicity, Eye irritation, Headache
Clinical narrative: From initial information received on 3/10/05 from another manufacturer (HQWYE906427JAN05) regarding an adverse event occurring in the USA, it was initially reported by a consumer that a male patient (date of birth and age not reported) received a dose of IPOL on 5/12/04. The lot number, route and site of administration were not reported. An unspecified amount of time later that same year, the patient developed brain damage, neurological symptoms, immune system disorder, psychomotor hyperactivity, emotional disorder, personality change, malaise, lethargy, retching, headache, dehydration, eye irritation, impaired pupillary reflex, temperature regulation disorder, pharyngolaryngeal pain, pain in extremities, predisposition to disease, mydriasis, skin discoloration, abnormal feeling, metal poisoning and neurotoxicity. It is unknown whether the patient recovered from any of these events. The reporter of this case is the same reporter as case 200500529. (OMIC)
Sex: M
Vaccine: DTAP, HEP, HIBV, IPV, MMR, PNC, VARCEL, MMR, VARCEL, IPV, IPV
Symptoms: Hypothermia, Immune system disorder, Laryngitis, Lethargy, Malaise
Clinical narrative: From initial information received on 3/10/05 from another manufacturer (HQWYE906427JAN05) regarding an adverse event occurring in the USA, it was initially reported by a consumer that a male patient (date of birth and age not reported) received a dose of IPOL on 5/12/04. The lot number, route and site of administration were not reported. An unspecified amount of time later that same year, the patient developed brain damage, neurological symptoms, immune system disorder, psychomotor hyperactivity, emotional disorder, personality change, malaise, lethargy, retching, headache, dehydration, eye irritation, impaired pupillary reflex, temperature regulation disorder, pharyngolaryngeal pain, pain in extremities, predisposition to disease, mydriasis, skin discoloration, abnormal feeling, metal poisoning and neurotoxicity. It is unknown whether the patient recovered from any of these events. The reporter of this case is the same reporter as case 200500529. (OMIC)
Sex: M
Vaccine: DTAP, HEP, HIBV, IPV, MMR, PNC, VARCEL, MMR, VARCEL, IPV, IPV
Symptoms: Mydriasis, Nervous system disorder, Neurotoxicity, Personality disorder, Pharyngitis
Clinical narrative: From initial information received on 3/10/05 from another manufacturer (HQWYE906427JAN05) regarding an adverse event occurring in the USA, it was initially reported by a consumer that a male patient (date of birth and age not reported) received a dose of IPOL on 5/12/04. The lot number, route and site of administration were not reported. An unspecified amount of time later that same year, the patient developed brain damage, neurological symptoms, immune system disorder, psychomotor hyperactivity, emotional disorder, personality change, malaise, lethargy, retching, headache, dehydration, eye irritation, impaired pupillary reflex, temperature regulation disorder, pharyngolaryngeal pain, pain in extremities, predisposition to disease, mydriasis, skin discoloration, abnormal feeling, metal poisoning and neurotoxicity. It is unknown whether the patient recovered from any of these events. The reporter of this case is the same reporter as case 200500529. (OMIC)
Sex: M
Vaccine: DTAP, HEP, HIBV, IPV, MMR, PNC, VARCEL, MMR, VARCEL, IPV, IPV
Symptoms: Psychomotor hyperactivity, Pupillary reflex impaired, Pyrexia, Retching, Skin discolouration
Clinical narrative: From initial information received on 3/10/05 from another manufacturer (HQWYE906427JAN05) regarding an adverse event occurring in the USA, it was initially reported by a consumer that a male patient (date of birth and age not reported) received a dose of IPOL on 5/12/04. The lot number, route and site of administration were not reported. An unspecified amount of time later that same year, the patient developed brain damage, neurological symptoms, immune system disorder, psychomotor hyperactivity, emotional disorder, personality change, malaise, lethargy, retching, headache, dehydration, eye irritation, impaired pupillary reflex, temperature regulation disorder, pharyngolaryngeal pain, pain in extremities, predisposition to disease, mydriasis, skin discoloration, abnormal feeling, metal poisoning and neurotoxicity. It is unknown whether the patient recovered from any of these events. The reporter of this case is the same reporter as case 200500529. (OMIC)
Sex: F
Vaccine: DTAP, HEP, HIBV, IPV, MMR, PNC, VARCEL, MMR, VARCEL, IPV, IPV
Symptoms: Dehydration, Drug toxicity, Eye irritation, Feeling abnormal, Headache
Clinical narrative: From initial information received on 3/10/05 from another manufacturer (reference number HQWYE866626JAN05) regarding an adverse event occurring in the USA, it was initially reported by a consumer that a female patient (date of birth and age not reported) received a dose of IPOL on 5/12/04. The lot number, route and site of administration were not reported. Sometime later that same year, the patient developed metal poisoning, neurotoxicity , personality change, feeling abnormal, lethargy, malaise, dehydration, retching, headache, predisposition to disease, eye irritation, pharyngolaryngeal pain, pain in extremity and medication error. It is unknown whether the patient recovered from any of the events. The reporter of this case is the same reporter as case 200500528. (OMIC)
Sex: F
Vaccine: DTAP, HEP, HIBV, IPV, MMR, PNC, VARCEL, MMR, VARCEL, IPV, IPV
Symptoms: Immune system disorder, Lethargy, Malaise, Medication error, Multiple sclerosis
Clinical narrative: From initial information received on 3/10/05 from another manufacturer (reference number HQWYE866626JAN05) regarding an adverse event occurring in the USA, it was initially reported by a consumer that a female patient (date of birth and age not reported) received a dose of IPOL on 5/12/04. The lot number, route and site of administration were not reported. Sometime later that same year, the patient developed metal poisoning, neurotoxicity , personality change, feeling abnormal, lethargy, malaise, dehydration, retching, headache, predisposition to disease, eye irritation, pharyngolaryngeal pain, pain in extremity and medication error. It is unknown whether the patient recovered from any of the events. The reporter of this case is the same reporter as case 200500528. (OMIC)
Sex: F
Vaccine: DTAP, HEP, HIBV, IPV, MMR, PNC, VARCEL, MMR, VARCEL, IPV, IPV
Symptoms: Mydriasis, Neurotoxicity, Pain, Parkinsonism, Personality disorder
Clinical narrative: From initial information received on 3/10/05 from another manufacturer (reference number HQWYE866626JAN05) regarding an adverse event occurring in the USA, it was initially reported by a consumer that a female patient (date of birth and age not reported) received a dose of IPOL on 5/12/04. The lot number, route and site of administration were not reported. Sometime later that same year, the patient developed metal poisoning, neurotoxicity , personality change, feeling abnormal, lethargy, malaise, dehydration, retching, headache, predisposition to disease, eye irritation, pharyngolaryngeal pain, pain in extremity and medication error. It is unknown whether the patient recovered from any of the events. The reporter of this case is the same reporter as case 200500528. (OMIC)
Sex: F
Vaccine: DTAP, HEP, HIBV, IPV, MMR, PNC, VARCEL, MMR, VARCEL, IPV, IPV
Symptoms: Pharyngolaryngeal pain, Retching
Clinical narrative: From initial information received on 3/10/05 from another manufacturer (reference number HQWYE866626JAN05) regarding an adverse event occurring in the USA, it was initially reported by a consumer that a female patient (date of birth and age not reported) received a dose of IPOL on 5/12/04. The lot number, route and site of administration were not reported. Sometime later that same year, the patient developed metal poisoning, neurotoxicity , personality change, feeling abnormal, lethargy, malaise, dehydration, retching, headache, predisposition to disease, eye irritation, pharyngolaryngeal pain, pain in extremity and medication error. It is unknown whether the patient recovered from any of the events. The reporter of this case is the same reporter as case 200500528. (OMIC)
Sex: F
Vaccine: DTAP, HEP, HIBV, IPV, MMR, PNC, VARCEL, MMR, VARCEL, IPV, IPV
Symptoms: Dehydration, Drug toxicity, Eye irritation, Headache, Immune system disorder
Clinical narrative: From initial information received on 3/10/05 from another manufacturer (reference number HQWYE866626JAN05) regarding an adverse event occurring in the USA, it was initially reported by a consumer that a female patient (date of birth and age not reported) received a dose of IPOL on 5/12/04. The lot number, route and site of administration were not reported. Sometime later that same year, the patient developed metal poisoning, neurotoxicity , personality change, feeling abnormal, lethargy, malaise, dehydration, retching, headache, predisposition to disease, eye irritation, pharyngolaryngeal pain, pain in extremity and medication error. It is unknown whether the patient recovered from any of the events. The reporter of this case is the same reporter as case 200500528. (OMIC)
Sex: F
Vaccine: DTAP, HEP, HIBV, IPV, MMR, PNC, VARCEL, MMR, VARCEL, IPV, IPV
Symptoms: Lethargy, Malaise, Medication error, Personality disorder, Pharyngolaryngeal pain
Clinical narrative: From initial information received on 3/10/05 from another manufacturer (reference number HQWYE866626JAN05) regarding an adverse event occurring in the USA, it was initially reported by a consumer that a female patient (date of birth and age not reported) received a dose of IPOL on 5/12/04. The lot number, route and site of administration were not reported. Sometime later that same year, the patient developed metal poisoning, neurotoxicity , personality change, feeling abnormal, lethargy, malaise, dehydration, retching, headache, predisposition to disease, eye irritation, pharyngolaryngeal pain, pain in extremity and medication error. It is unknown whether the patient recovered from any of the events. The reporter of this case is the same reporter as case 200500528. (OMIC)
Sex: F
Vaccine: DTAP, HEP, HIBV, IPV, MMR, PNC, VARCEL, MMR, VARCEL, IPV, IPV
Symptoms: Retching
Clinical narrative: From initial information received on 3/10/05 from another manufacturer (reference number HQWYE866626JAN05) regarding an adverse event occurring in the USA, it was initially reported by a consumer that a female patient (date of birth and age not reported) received a dose of IPOL on 5/12/04. The lot number, route and site of administration were not reported. Sometime later that same year, the patient developed metal poisoning, neurotoxicity , personality change, feeling abnormal, lethargy, malaise, dehydration, retching, headache, predisposition to disease, eye irritation, pharyngolaryngeal pain, pain in extremity and medication error. It is unknown whether the patient recovered from any of the events. The reporter of this case is the same reporter as case 200500528. (OMIC)
Sex: F
Vaccine: DTAP, HEP, HIBV, IPV, MMR, PNC, VARCEL, MMR, VARCEL, IPV, IPV
Symptoms: Dehydration, Drug toxicity, Eye irritation, Headache, Laryngitis
Clinical narrative: From initial information received on 3/10/05 from another manufacturer (reference number HQWYE866626JAN05) regarding an adverse event occurring in the USA, it was initially reported by a consumer that a female patient (date of birth and age not reported) received a dose of IPOL on 5/12/04. The lot number, route and site of administration were not reported. Sometime later that same year, the patient developed metal poisoning, neurotoxicity , personality change, feeling abnormal, lethargy, malaise, dehydration, retching, headache, predisposition to disease, eye irritation, pharyngolaryngeal pain, pain in extremity and medication error. It is unknown whether the patient recovered from any of the events. The reporter of this case is the same reporter as case 200500528. (OMIC)
Sex: F
Vaccine: DTAP, HEP, HIBV, IPV, MMR, PNC, VARCEL, MMR, VARCEL, IPV, IPV
Symptoms: Lethargy, Malaise, Medication error, Pain, Personality disorder
Clinical narrative: From initial information received on 3/10/05 from another manufacturer (reference number HQWYE866626JAN05) regarding an adverse event occurring in the USA, it was initially reported by a consumer that a female patient (date of birth and age not reported) received a dose of IPOL on 5/12/04. The lot number, route and site of administration were not reported. Sometime later that same year, the patient developed metal poisoning, neurotoxicity , personality change, feeling abnormal, lethargy, malaise, dehydration, retching, headache, predisposition to disease, eye irritation, pharyngolaryngeal pain, pain in extremity and medication error. It is unknown whether the patient recovered from any of the events. The reporter of this case is the same reporter as case 200500528. (OMIC)
Sex: F
Vaccine: DTAP, HEP, HIBV, IPV, MMR, PNC, VARCEL, MMR, VARCEL, IPV, IPV
Symptoms: Laryngitis, Lethargy, Malaise, Medication error, Pain
Clinical narrative: From initial information received on 3/10/05 from another manufacturer (reference number HQWYE866626JAN05) regarding an adverse event occurring in the USA, it was initially reported by a consumer that a female patient (date of birth and age not reported) received a dose of IPOL on 5/12/04. The lot number, route and site of administration were not reported. Sometime later that same year, the patient developed metal poisoning, neurotoxicity , personality change, feeling abnormal, lethargy, malaise, dehydration, retching, headache, predisposition to disease, eye irritation, pharyngolaryngeal pain, pain in extremity and medication error. It is unknown whether the patient recovered from any of the events. The reporter of this case is the same reporter as case 200500528. (OMIC)
Sex: F
Vaccine: DTAP, HEP, HIBV, IPV, MMR, PNC, VARCEL, MMR, VARCEL, IPV, IPV
Symptoms: Personality disorder, Pharyngitis, Retching
Clinical narrative: From initial information received on 3/10/05 from another manufacturer (reference number HQWYE866626JAN05) regarding an adverse event occurring in the USA, it was initially reported by a consumer that a female patient (date of birth and age not reported) received a dose of IPOL on 5/12/04. The lot number, route and site of administration were not reported. Sometime later that same year, the patient developed metal poisoning, neurotoxicity , personality change, feeling abnormal, lethargy, malaise, dehydration, retching, headache, predisposition to disease, eye irritation, pharyngolaryngeal pain, pain in extremity and medication error. It is unknown whether the patient recovered from any of the events. The reporter of this case is the same reporter as case 200500528. (OMIC)
Age: 4.0
Sex: M
Vaccine: DTAP, IPV
Symptoms: Injection site erythema, Injection site oedema, Tenderness
Clinical narrative: From initial information received on 26Oct04 from a health care professional regarding an adverse event occurring, it was reported that a 5 year old male pt received a Daptacel vaccination, lot number C1699AA and an IPOL vaccination, lot number X0800 administered as an unspecified site on 16Aug04. Reportedly three days later the pt developed redness of the entire thigh, swelling and tenderness. Reportedly the pt recovered from this experience. The reporter of this case is the same reporter of cases 200402851, 200402912 and 200403466.
Age: 5.0
Sex: M
Vaccine: DTAP, IPV, MMR, DTAP, IPV, MMR
Symptoms: Agitation, Injection site induration, Injection site swelling, Injection site warmth, Pruritus
Clinical narrative: From initial information received on 28Dec04 from a RN regarding an adverse event occurring. It was reported that a 5 yr old male pt received the fifth dose of Tripedia, lot number U1316CA, administered IM in the left thigh, the fourth dose of Ipol, lot number X1240, admin SC in the right thigh, and the second dose of measles, mumps and rubella vaccine, lot number 0345P, and admin SC in the right thigh on 21Dec04. One day later on 22Dec04 at 4:50PM, the pt developed a grapefruit size knot on his leg with warmth and itching. He was treated with a warm compress and Benadryl. On 23Dec04, the pt developed swelling from the groin to the kneecap area below the shot and a purplish, raised area measuring three by three inches in diameter. He also became agitated. He was treated with a warm compress, Benadryl and ibuprofen. The pt recovered from these events.
Age: 5.0
Sex: M
Vaccine: DTAP, IPV, MMR, DTAP, IPV, MMR
Symptoms: Skin discolouration, Swelling
Clinical narrative: From initial information received on 28Dec04 from a RN regarding an adverse event occurring. It was reported that a 5 yr old male pt received the fifth dose of Tripedia, lot number U1316CA, administered IM in the left thigh, the fourth dose of Ipol, lot number X1240, admin SC in the right thigh, and the second dose of measles, mumps and rubella vaccine, lot number 0345P, and admin SC in the right thigh on 21Dec04. One day later on 22Dec04 at 4:50PM, the pt developed a grapefruit size knot on his leg with warmth and itching. He was treated with a warm compress and Benadryl. On 23Dec04, the pt developed swelling from the groin to the kneecap area below the shot and a purplish, raised area measuring three by three inches in diameter. He also became agitated. He was treated with a warm compress, Benadryl and ibuprofen. The pt recovered from these events.
Age: 5.0
Sex: M
Vaccine: DTAP, IPV, MMR, DTAP, IPV, MMR
Symptoms: Agitation, Feeling hot, Injection site mass, Injection site oedema, Injection site swelling
Clinical narrative: From initial information received on 28Dec04 from a RN regarding an adverse event occurring. It was reported that a 5 yr old male pt received the fifth dose of Tripedia, lot number U1316CA, administered IM in the left thigh, the fourth dose of Ipol, lot number X1240, admin SC in the right thigh, and the second dose of measles, mumps and rubella vaccine, lot number 0345P, and admin SC in the right thigh on 21Dec04. One day later on 22Dec04 at 4:50PM, the pt developed a grapefruit size knot on his leg with warmth and itching. He was treated with a warm compress and Benadryl. On 23Dec04, the pt developed swelling from the groin to the kneecap area below the shot and a purplish, raised area measuring three by three inches in diameter. He also became agitated. He was treated with a warm compress, Benadryl and ibuprofen. The pt recovered from these events.
Age: 5.0
Sex: M
Vaccine: DTAP, IPV, MMR, DTAP, IPV, MMR
Symptoms: Pruritus, Similar reaction on previous exposure to drug, Skin discolouration
Clinical narrative: From initial information received on 28Dec04 from a RN regarding an adverse event occurring. It was reported that a 5 yr old male pt received the fifth dose of Tripedia, lot number U1316CA, administered IM in the left thigh, the fourth dose of Ipol, lot number X1240, admin SC in the right thigh, and the second dose of measles, mumps and rubella vaccine, lot number 0345P, and admin SC in the right thigh on 21Dec04. One day later on 22Dec04 at 4:50PM, the pt developed a grapefruit size knot on his leg with warmth and itching. He was treated with a warm compress and Benadryl. On 23Dec04, the pt developed swelling from the groin to the kneecap area below the shot and a purplish, raised area measuring three by three inches in diameter. He also became agitated. He was treated with a warm compress, Benadryl and ibuprofen. The pt recovered from these events.
Age: 0.57
Sex: M
Vaccine: DTAP, HEP, HIBV, IPV, PNC, DTAP, HIBV, IPV, HEP, DTAP, HEP, HIBV, IPV, PNC, DTAP, HIBV, IPV
Symptoms: Bacterial infection, Laboratory test abnormal, Leukocytosis, Pulmonary embolism, Pyrexia
Clinical narrative: From initial information received on 3/10/05 from another manufacturer (HQWYE781121JAN05), regarding an adverse event occurring in the USA, it was initially reported by a health care facility that a seven month old male patient received ACTHIB, a dose of IPOL, and a dose of TRIPEDIA on 9/28/04. The lot numbers, routes and sites of administration were not reported. Six days later, the patient developed pseudomonal sepsis and multiple pulmonary emboli. He expired that same day. It was not reported whether an autopsy was completed. From additional information received on 4/21/05 from a registered nurse, it was reported that an autopsy was performed on this patient and the report has been sent. The reporter was unsure whether the report could be provided to the manufacturer. No other information was provided at this time. From additional information received on 5/13/05 from a registered nurse, it was reported that they must decline the request for copies of the medical records and autopsy report. No further information anticipated, this case is considered closed.
Age: 0.57
Sex: M
Vaccine: DTAP, HEP, HIBV, IPV, PNC, DTAP, HIBV, IPV, HEP, DTAP, HEP, HIBV, IPV, PNC, DTAP, HIBV, IPV
Symptoms: Sepsis
Clinical narrative: From initial information received on 3/10/05 from another manufacturer (HQWYE781121JAN05), regarding an adverse event occurring in the USA, it was initially reported by a health care facility that a seven month old male patient received ACTHIB, a dose of IPOL, and a dose of TRIPEDIA on 9/28/04. The lot numbers, routes and sites of administration were not reported. Six days later, the patient developed pseudomonal sepsis and multiple pulmonary emboli. He expired that same day. It was not reported whether an autopsy was completed. From additional information received on 4/21/05 from a registered nurse, it was reported that an autopsy was performed on this patient and the report has been sent. The reporter was unsure whether the report could be provided to the manufacturer. No other information was provided at this time. From additional information received on 5/13/05 from a registered nurse, it was reported that they must decline the request for copies of the medical records and autopsy report. No further information anticipated, this case is considered closed.
Age: 0.57
Sex: M
Vaccine: DTAP, HEP, HIBV, IPV, PNC, DTAP, HIBV, IPV, HEP, DTAP, HEP, HIBV, IPV, PNC, DTAP, HIBV, IPV
Symptoms: Pulmonary embolism, Sepsis
Clinical narrative: From initial information received on 3/10/05 from another manufacturer (HQWYE781121JAN05), regarding an adverse event occurring in the USA, it was initially reported by a health care facility that a seven month old male patient received ACTHIB, a dose of IPOL, and a dose of TRIPEDIA on 9/28/04. The lot numbers, routes and sites of administration were not reported. Six days later, the patient developed pseudomonal sepsis and multiple pulmonary emboli. He expired that same day. It was not reported whether an autopsy was completed. From additional information received on 4/21/05 from a registered nurse, it was reported that an autopsy was performed on this patient and the report has been sent. The reporter was unsure whether the report could be provided to the manufacturer. No other information was provided at this time. From additional information received on 5/13/05 from a registered nurse, it was reported that they must decline the request for copies of the medical records and autopsy report. No further information anticipated, this case is considered closed.